Abstract
The development of antiviral drugs is crucial for the prevention and treatment of viral infections. Bioinformatics has become an essential tool in the discovery and optimization of antiviral drugs. By integrating molecular biology, computational biology, and drug design, bioinformatics approaches enable the identification of viral targets, the prediction of drug interactions, and the optimization of drug efficacy. This article reviews the applications of bioinformatics in antiviral drug development, focusing on viral genome analysis, drug repurposing, molecular docking, and structure-based drug design. We also discuss the challenges and future directions in the use of bioinformatics for antiviral drug discovery.
All articles published in the American Journal of Bioinformatics (AJB) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Under this license, authors retain full copyright of their work and grant permission to anyone to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Conditions:
-
Attribution: Appropriate credit must be given to the original author(s) and the source, a link to the license must be provided, and any changes made must be indicated.
-
No additional restrictions: You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This open-access license ensures that scholarly work published in AJB is freely accessible and usable, promoting knowledge dissemination and academic collaboration worldw